PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Mental Health Depression

Brain imaging study pinpoints neurotransmitter that may be responsible for yoga’s mood-boosting effect

by Beth Ellwood
December 29, 2020
Reading Time: 3 mins read
(Photo credit: psdesign1)

(Photo credit: psdesign1)

Share on TwitterShare on Facebook

A recent study found tentative evidence to suggest that yoga exerts its mood-boosting effect by increasing GABA activity among individuals with depression. The study, published in the Journal of Alternative and Complementary Medicine, further suggests that yoga’s beneficial effects on mood are time-limited.

While medication can be highly effective in reducing symptoms of major depressive disorder (MDD), many individuals do not reach remission without additional treatment. Interestingly, yoga interventions have shown promise in reducing depressive symptoms, although it is not clear why.

“Integrative medicine includes consideration of the mind-body interface. Yoga can be used to address many form of illness especially those due to Life Style Choices,” said study author Chris C. Streeter, an associate professor of psychiatry and neurology at the Boston University School of Medicine.

“Many form of western medicine help reduce symptoms but to do completely return people to wellness, the addition of yoga to a treatment regime can increase wellness/decrease symptoms.”

Streeter and her colleagues set out to explore the idea that a yoga intervention increases mood through its effect on an amino acid neurotransmitter called gamma-aminobutyric acid (GABA). The researchers were motivated by findings linking the neurotransmitter to depression.

Specifically, insufficiency in the GABA system has been linked to depressive symptoms, and individuals with MDD have been found to have low GABA levels. On the other hand, yoga interventions have been purported to increase GABA activity.

Streeter and team recruited 32 adults with MDD for a 12-week yoga intervention. Patients were assigned to either a high-dose intervention of three yoga sessions a week or a low-dose intervention of two yoga sessions a week. The yoga sessions included 60 minutes of Iyengar yoga, 10 minutes of relaxation, 20 minutes of breathing practice, and homework exercises.

Throughout the study, the patients underwent magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) scans before the 12-week intervention and following the intervention. At the end of the intervention, all participants took part in an additional 90-minute yoga session and then a third and final brain scan.

Google News Preferences Add PsyPost to your preferred sources

The researchers found that the overall direction of the data when considering all participants, pointed to increases in GABA levels between the first and last scans, and the second and third scans. However, there were no differences between the high-dose yoga and low-dose yoga groups.

The findings provide evidence that “yoga is a low cost, low side effect means of improving mood and decreasing anxiety,” Streeter told PsyPost.

The researchers did find that the number of days since a subject’s latest yoga class appeared to be important, perhaps more so than the amount of yoga practice. Specifically, those who showed increased GABA levels at Scan 2 compared to Scan 1, had an average of 3.93 days since their last yoga session. Those whose GABA levels did not go up had an average of 7.83 days since their last yoga session.

“It is probable that the effects of yoga sessions, like pharmacologic treatments, are time limited,” the researchers remark. “The yoga tradition advocates daily practice. The increase in GABA levels seen after a yoga intervention was observed after an average of 4 days, but no longer observed after an average of 8 days.”

The participants had also completed assessments of depressive symptoms at various timepoints. The researchers found that subjects’ GABA levels were not significantly linked to their depressive symptoms. However, changes in depressive symptoms were inversely tied to GABA levels among the high-dose group. As the authors say, this means that depressive symptoms dropped as GABA levels rose.

With a very small sample size, the authors express that their findings are encouraging yet tentative, and future studies should explore the topic among a larger sample.

“The use of yoga for depression needs to be compared to antidepressants in a randomized controlled trial and in combination with anti-depressants,” Streeter said.

Still, the findings suggest that the GABA system may be a mechanism through which yoga improves mood, and practicing yoga at least one time a week may be the key to seeing these benefits.

“There are no magic bullets or pills that completely treat depression or anxiety — yoga is another tool available,” Streeter added. “Many stress-related disorders are associated with an imbalance in the autonomic nervous system with too much sympathetic (fight or flight) and to little parasympathetic (rest, renewal and social engagement). Yoga helps to correct this imbalance.”

The study, “Thalamic Gamma Aminobutyric Acid Level Changes in Major Depressive Disorder After a 12-Week Iyengar Yoga and Coherent Breathing Intervention”, was authored by Chris C. Streeter, Patricia L. Gerbarg, Richard P. Brown, Tammy M. Scott, Greylin H. Nielsen, Liz Owen, Osamu Sakai, Jennifer T. Sneider, Maren B. Nyer, and Marisa M. Silveri.

RELATED

Optimistic individuals are more likely to respond to SSRI antidepressants
Depression

Believing in a “chemical imbalance” might keep patients on antidepressants longer

April 19, 2026
Little-known psychedelic drug reduces motivation to take heroin in rats, study finds
Anxiety

Researchers find DMT provides longer-lasting antidepressant effects than S-ketamine in animal models

April 15, 2026
Antidepressants may diminish psilocybin’s effects even after discontinuation
Depression

Psychedelic therapy and traditional antidepressants show similar results under open-label conditions

April 14, 2026
Study finds microdosing LSD is not effective in reducing ADHD symptoms
Depression

Low doses of LSD alter emotional brain responses in people with mild depression

April 12, 2026
Cognitive dissonance helps explain why Trump supporters remain loyal, new research suggests
Anxiety

Stacking bad habits triples the risk of co-occurring anxiety and depression in teenagers

April 11, 2026
Personalient individuals are happier due to smoother social relations
Depression

New research links meaning in life to lower depression rates

April 8, 2026
A common calorie-free sweetener alters brain activity and appetite control, new research suggests
Anxiety

High sugar intake is linked to increased odds of depression and anxiety in new study

April 8, 2026
Depression

A smaller social network increases loneliness more drastically for those with depression

April 7, 2026

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader. We also syndicate to Apple News.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • How cognitive ability and logical intuition evolve during middle and high school
  • Former Christians express more progressive political views than lifelong nonbelievers
  • New psychology research reveals your face might determine how easily people remember your name
  • Certainty in your feelings toward your partner predicts relationship happiness and mental well-being
  • New neuroscience research shows how slowing your breathing alters your perception of the people around you

Psychology of Selling

  • When company shakeups breed envy, salespeople may cut corners and eye the exit
  • Study finds Instagram micro-celebrities can shift brand attitudes and buying intent through direct engagement
  • Salespeople who feel they’re making a difference may outperform those chasing commissions
  • Five persuasive approaches and when each one works best for marketers
  • When salespeople feel free and connected to their boss, they’re less likely to quit

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc